Sign Up to like & get
recommendations!
0
Published in 2017 at "Cochrane Database of Systematic Reviews"
DOI: 10.1002/14651858.cd011178.pub2
Abstract: Reason for withdrawal from publication This protocol has been withdrawn as the author team is unable to progress to the final review stage. This title is not open to a new author team as it…
read more here.
Keywords:
treating erectile;
inhibitors treating;
erectile dysfunction;
cardiovascular safety ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Joint bone spine"
DOI: 10.1016/j.jbspin.2020.05.010
Abstract: HIGHLIGHTS • baricitinib and tofacitinib are effective in patients with Rhupus • JAK inhibitors are an alternative option in patients with refractory SLE • JAK inhibitors have a steroid-sparing effect in patients with Rhupus
read more here.
Keywords:
inhibitors treating;
patients rhupus;
kinases inhibitors;
treating patients ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "ACS medicinal chemistry letters"
DOI: 10.1021/acsmedchemlett.3c00122
Abstract: Provided herein are 1,2,4-triazine derivatives used as NLRP3 inhibitors, their pharmaceutical compositions, the use of such compounds in treating diseases and processes for preparing such compounds.
read more here.
Keywords:
treating diseases;
chemistry;
derivatives nlrp3;
inhibitors treating ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2019.1702970
Abstract: ABSTRACT Introduction: Scientific evidence on subjects treated with statin or other lipid-lowering treatments has established that treatments aiming to lower low-density lipoprotein cholesterol (LDL-C) can reduce atherosclerosis. PCSK9 inhibitors (PCSK9-i), thanks to their efficacy in…
read more here.
Keywords:
inhibitors treating;
treating hypercholesterolemia;
pcsk9 inhibitors;
pcsk9 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2017.1351540
Abstract: ABSTRACT Introduction: The prevalence of Alzheimer’s disease (AD) continues to rise, while treatment options for cognitive impairment are limited. Acetylcholinesterase inhibitors (AChEIs) aim to provide symptomatic benefit for cognitive decline, however these drugs are not…
read more here.
Keywords:
treatment;
inhibitors treating;
safety;
acetylcholinesterase inhibitors ... See more keywords